WHO ICTRP trial
A Phase I/ II Clinical Trial: Autologous CD34+ Cell Transplantation for Bone and…
JPRN-UMIN000002993 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000002993 |
|---|---|
| Public title | A Phase I/ II Clinical Trial: Autologous CD34+ Cell Transplantation for Bone and Vascular Healing in Patients with Non-Union Fracture |
| Scientific title | A Phase I/ II Clinical Trial: Autologous CD34+ Cell Transplantation for Bone and Vascular Healing in Patients with Non-Union Fracture - Cellular Therapy for Patients with Non-Union Fracture |
| Primary sponsor | Ryosuke Kuroda, M.D., Ph.D. |
| Secondary sponsors | Foundation for Biomedical Research and Innovation, Institute of Biomedical Research and Innovation Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase I,II |
| Countries | Japan |
| Conditions | Non-Union Fracture |
| Interventions | Operation for non-union fracture (re-fixation) and transplantation of CD34+ cells with atelocollagen as a scaffold |
| Registration date | Aug 1, 2010 |
| Target size | 17 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: